On June 23, 2020, the GNS team was joined by Craig Davis, Sr. Director of Translational Oncology at Pfizer, to discuss the use of our AI platform for identifying drivers of immune checkpoint inhibitor response. We covered how companies leading the charge on ICI development are faced with many questions including:
Access the recording by filling out the form to the right.
Craig Davis, PhD
Senior Director of Translational Oncology
Rahul Das, PhD
Associate Director of Precision Medicine
Ellen Gordon, PhD
Principal, Client Solutions